← SynDRA
CI-218872
SynDRA canonical compound SYN0000700 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | GABRA1 |
| Mechanism of action | GABA receptor agonist |
All known targets
- GABRA1
- GABRA2
- GABRA3
- GABRA5
- GABRB2
- GABRG2
Mechanisms of action (all sources)
- GABA receptor agonist
- benzodiazepine receptor agonist
- GABRB2 INHIBITOR
- GABRA1 INHIBITOR
- GABRA5 INHIBITOR
- GABRG2 INHIBITOR
- GABRA2 INHIBITOR
- GABRA3 INHIBITOR
Cross-references
Synonyms
- CL-218872
- CL 218,872
- 3-methyl-6-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazine
- CHEMBL13662
- 3-Methyl-6-(3-(trifluoromethyl)phenyl)-1,2,4-triazolo(4,2-b)pyridazine
- 1,2,4-Triazolo(4,3-b)pyridazine, 3-methyl-6-(3-(trifluoromethyl)phenyl)-
- 3-Methyl-6-(3-(trifluoromethyl)phenyl)-[1,2,4]triazolo[4,3-b]pyridazine
- 3-Methyl-6-[-3-(trifluoromethyl)phenyl]-1,2,4-triazolo[4,3-b]pyridazine
- 3-Methyl-6-[3-(trifluoromethyl)phenyl]-1,2,4-triazolo-(4,3-b)pyridazine
- CL-218,872
- O7GR5XL5B5
- CL218,872
- RefChem:911519
- DTXCID10139219
- MFCD00674912
- CL218872
- Tocris-1709
- UNII-O7GR5XL5B5
- MLS000860066
- orb1298821
- SCHEMBL1320758
- SCHEMBL29469726
- CHEBI:92018
- GLXC-01850
- HMS2235F15
- HMS3268A16
- HMS3369C09
- HMS3412D18
- HMS3676D18
- BDBM50026756
- EBC-06830
- PDSP1_000634
- PDSP1_001766
- PDSP2_000629
- PDSP2_001749
- AKOS024456755
- NCGC00025269-01
- NCGC00025269-02
- AC-33570
Look up CI-218872 in the interactive SynDRA portal →